| Journal | American journal of preventive medicine |
| Study Type | Clinical Study |
| Population | Human participants |
This item covers developments relevant to cannabis medicine and clinical practice. Clinicians monitoring evidence in this area should review the source material.
The ways cannabis is consumed, or modes of use, have increased and diversified in recent years, especially among young people. Associations of multimodal cannabis use (1, 2, or 3+ modes) with adverse events were examined among adolescents and young adults. Data from the 2022-2023 National Survey of Drug Use and Health, including non-institutionalized US civilians aged 12-25 reporting past-year cannabis use (n=13,284), were used. Cannabis users were asked about the type (smoking, vaping, dabbing, eating/drinking, and other) and number of cannabis modes used in the past year. Multivariable-adjusted analyses assessed associations of number of modes with adverse events, adjusted for sociodemographic characteristics and frequency of use. Among 51,435 individuals (45.8% adolescents, 51.0% female, 48.1% non-Hispanic white), 13,284 (26.1%) reported past-year cannabis use. Individuals more frequently used 3+ modes (37.5%) than one (34.0%) or two (28.5%), with the most common being smoking (83.9
“This is a development worth tracking. The clinical implications will become clearer as more evidence accumulates.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
This study item was assembled from normalized source metadata and pipeline scoring.
